1 / 34

The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD

The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida. PHARMACOKINETICS what the body does to the drug PHARMACODYNAMICS what the drug does to the body. Pharmacokinetics conc. vs time. Pharmacodynamics conc. vs effect. 0.4. 1. Conc.

jodie
Download Presentation

The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida

  2. PHARMACOKINETICS what the body does to the drug PHARMACODYNAMICS what the drug does to the body

  3. Pharmacokinetics conc. vs time Pharmacodynamics conc. vs effect 0.4 1 Conc. Effect 0.0 0 25 Time 0 Conc (log) 10 -4 10 -3 PK/PD effect vs time 1 Effect 0 0 25 Time

  4. Pharmacokinetics the time course of drug and metabolite concentrations in the body

  5. Pharmacokinetics helps to optimize drug therapy: dose dosage regimen dosage form

  6. What happens to a drug after its administration ? ("Fate of drug") Liberation Absorption Distribution Metabolism Excretion

  7. Pharmacokinetic Parameters Clearance Volume of distribution Half-life Bioavailability Protein Binding

  8. Clearance • quantifiesELIMINATION • is the volume of body fluid cleared per time unit (L/h, mL/min) • is usually constant

  9. CL = Q·E Q Blood Flow E Extraction Ratio Clearance Eliminating Organ

  10. Q Ci Co Eliminating Organ Clearance Parameters: Blood Flow, intrinsic clearance, protein binding Good prediction of changes in clearance Steady state

  11. High-extraction drugs Low-extraction drugs

  12. Clearance • Clearance can be calculated from • Excretion rate / Concentration e.g. (mg/h) / (mg/L) = L/h • Dose / Area under the curve (AUC) e.g. mg / (mg·h/L) = L/h

  13. Total body clearance is the sum of the individual organ clearances CL = CLren + CLhep + CLother Clearance

  14. Volume of Distribution Vd = X / Cp - quantifiesDISTRIBUTION - relates drug concentration (Cp) to amount of drug in the body (X) - gives information on the amount of drug distributed into the tissues

  15. Apparent Volume of Distribution X X V V C1 C2 C1 > C2 V < Vd C1 = X / V V = X / C1 C2 = X / Vd Vd = X / C2

  16. Volume of Distribution Dicloxacillin 0.1 L/kg Gentamicin (ECF)0.25 L/kg Antipyrine (TBW)0.60 L/kg Ciprofloxacin 1.8 L/kg Azithromycin 31 L/kg

  17. Half-Life Half-life is the time it takes for the concentration to fall to half of its previous value Half-life is a secondary pharmacokinetic parameter and depends on clearance and volume of distribution

  18. Half-Life k elimination rate constant CL clearance Vd volume of distribution

  19. Bioavailability - quantifies ABSORPTION f is the fraction of the administered dose that reaches the systemic circulation

  20. BioavailabilityRate and Extent of Absorption

  21. Protein Binding • reversibe vs. irreversible • linear vs. nonlinear • rapid equilibrium The free (unbound)concentration of the drug at the receptor site should be used in PK/PD correlations to make prediction for pharmacological activity

  22. vascular space extravascular space binding to extracellular biological material plasma protein binding blood cell binding, diffusion into blood cells, binding to intracellular biological material tissue cell binding, diffusion into tissue cells, binding to intracellular biological material

  23. Perfusate Dialysate Interstitium Capillary Cell Microdialysis

  24. Microdialysis

  25. Pharmacokinetic profile of cefpodoxime (400 mg oral dose, n = 6)

  26. Pharmacokinetic profile of cefixime (400 mg oral dose, n = 6) Mean ± SD

  27. Pharmacokinetics

  28. Dose Xc Drug in the central compartment Xp Drug in the peripheral compartment Drug eliminated Two-compartment model D k 10 Xc E k k 12 21 Xp

  29. Two-compartment model

  30. Short-term infusion

  31. Xc Drug in the central compartment Xps Drug in the shallow peripheral compartment Xpd Drug in the deep peripheral compartment Three-compartment model Xp d k k 31 13 D k Xc E 10 k k 12 21 Xp s • Dose • Drug eliminated

  32. Drug Delivery Pharmacokinetics Pharmacodynamics ? Biopharmaceutics ? PK-PD-Modeling

More Related